150 related articles for article (PubMed ID: 31978148)
1. Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey.
Racz B; Varadi A; Pearson PG; Petrukhin K
PLoS One; 2020; 15(1):e0228291. PubMed ID: 31978148
[TBL] [Abstract][Full Text] [Related]
2. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle.
Racz B; Varadi A; Kong J; Allikmets R; Pearson PG; Johnson G; Cioffi CL; Petrukhin K
J Biol Chem; 2018 Jul; 293(29):11574-11588. PubMed ID: 29871924
[TBL] [Abstract][Full Text] [Related]
3. A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.
Dobri N; Qin Q; Kong J; Yamamoto K; Liu Z; Moiseyev G; Ma JX; Allikmets R; Sparrow JR; Petrukhin K
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):85-95. PubMed ID: 23211825
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.
Cioffi CL; Dobri N; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Golden KC; Zhu L; Kitchen DB; Barnes KD; Racz B; Qin Q; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
J Med Chem; 2014 Sep; 57(18):7731-57. PubMed ID: 25210858
[TBL] [Abstract][Full Text] [Related]
5. Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4.
Wang Y; Connors R; Fan P; Wang X; Wang Z; Liu J; Kayser F; Medina JC; Johnstone S; Xu H; Thibault S; Walker N; Conn M; Zhang Y; Liu Q; Grillo MP; Motani A; Coward P; Wang Z
Bioorg Med Chem Lett; 2014 Jul; 24(13):2885-91. PubMed ID: 24835984
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.
Cioffi CL; Muthuraman P; Raja A; Varadi A; Racz B; Petrukhin K
J Med Chem; 2020 Oct; 63(19):11054-11084. PubMed ID: 32878437
[TBL] [Abstract][Full Text] [Related]
7. Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development.
Kim N; Priefer R
Eur J Med Chem; 2021 Dec; 226():113856. PubMed ID: 34547506
[TBL] [Abstract][Full Text] [Related]
8. Transgenic Mice Overexpressing Serum Retinol-Binding Protein Develop Progressive Retinal Degeneration through a Retinoid-Independent Mechanism.
Du M; Otalora L; Martin AA; Moiseyev G; Vanlandingham P; Wang Q; Farjo R; Yeganeh A; Quiambao A; Farjo KM
Mol Cell Biol; 2015 Aug; 35(16):2771-89. PubMed ID: 26055327
[TBL] [Abstract][Full Text] [Related]
9. Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration.
Du M; Phelps E; Balangue MJ; Dockins A; Moiseyev G; Shin Y; Kane S; Otalora L; Ma JX; Farjo R; Farjo KM
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4375–4383. PubMed ID: 28813718
[TBL] [Abstract][Full Text] [Related]
10. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4.
Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A
Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis.
Cioffi CL; Racz B; Varadi A; Freeman EE; Conlon MP; Chen P; Zhu L; Kitchen DB; Barnes KD; Martin WH; Pearson PG; Johnson G; Blaner WS; Petrukhin K
J Med Chem; 2019 Jun; 62(11):5470-5500. PubMed ID: 31079449
[TBL] [Abstract][Full Text] [Related]
12. Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease.
Cioffi CL; Racz B; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Zhu L; Kitchen DB; Barnes KD; Dobri N; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
J Med Chem; 2015 Aug; 58(15):5863-88. PubMed ID: 26181715
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
[TBL] [Abstract][Full Text] [Related]
14. Baseline Levels of Retinol-Binding Protein 4 and Vitamin A in Healthy Subjects, Stargardt Disease, and Geographic Atrophy Patients.
Janeschitz-Kriegl L; Cattaneo M; Scholl HPN
Ophthalmic Res; 2022; 65(3):351-360. PubMed ID: 35108705
[TBL] [Abstract][Full Text] [Related]
15. Discovery of phenylpyrrolidine derivatives as a novel class of retinol binding protein 4 (RBP4) reducers.
Nakamura S; Kamaura M; Akao Y; Nakamura N; Mizukami A; Goto A; Furuyama N; Cho N; Kasai S
Bioorg Med Chem; 2022 Jan; 54():116553. PubMed ID: 34953340
[TBL] [Abstract][Full Text] [Related]
16. Retinol binding protein 4 in dairy cows: its presence in colostrum and alteration in plasma during fasting, inflammation, and the peripartum period.
Abd Eldaim MA; Kamikawa A; Soliman MM; Ahmed MM; Okamatsu-Ogura Y; Terao A; Miyamoto T; Kimura K
J Dairy Res; 2010 Feb; 77(1):27-32. PubMed ID: 19785912
[TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551.
Fleury A; Lavé T; Jonsson F; Schmitt M; Hirkaler G; Polonchuk L; Breidenbach A
J Pharmacol Toxicol Methods; 2011; 63(1):123-33. PubMed ID: 20732434
[TBL] [Abstract][Full Text] [Related]
18. Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects.
Lee JW; Lee HR; Shim JY; Im JA; Lee DC
Endocr J; 2008 Oct; 55(5):811-8. PubMed ID: 18493106
[TBL] [Abstract][Full Text] [Related]
19. Regulation by FSH of the dynamic expression of retinol-binding protein 4 in the mouse ovary.
Jiang Y; Zhao Y; Chen S; Chen L; Li C; Zhou X
Reprod Biol Endocrinol; 2018 Mar; 16(1):25. PubMed ID: 29558965
[TBL] [Abstract][Full Text] [Related]
20. Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands.
Coward P; Conn M; Tang J; Xiong F; Menjares A; Reagan JD
Anal Biochem; 2009 Jan; 384(2):312-20. PubMed ID: 18952041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
